Sign In
Buy LMAT
$91.64
+0.0200 (+0.0218%)
At Close: Jun 03, 2026
New Strong Buy Stocks for March 4th
07:15am, Tuesday, 04'th Mar 2025
OPCH, LMAT, C, FFIN and IBCP have been added to the Zacks Rank #1 (Strong Buy) List on March 4, 2025.
LeMaitre to Participate at Upcoming Investor Conferences in March
05:06pm, Monday, 03'rd Mar 2025
BURLINGTON, Mass., March 03, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in three upcoming investor conferences in March.
LeMaitre (LMAT) Upgraded to Buy: Here's What You Should Know
01:05pm, Monday, 03'rd Mar 2025
LeMaitre (LMAT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
LeMaitre Vascular, Inc. (LMAT) Q4 2024 Earnings Call Transcript
11:16pm, Thursday, 27'th Feb 2025
LeMaitre Vascular, Inc. (NASDAQ:LMAT ) Q4 2024 Earnings Conference Call February 27, 2025 5:00 PM ET Company Participants J.J. Pellegrino - Chief Financial Officer George LeMaitre - Chief Executive Of
LeMaitre Vascular (LMAT) Meets Q4 Earnings Estimates
07:45pm, Thursday, 27'th Feb 2025
LeMaitre Vascular (LMAT) came out with quarterly earnings of $0.49 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.38 per share a year ago.
LeMaitre Q4 2024 Financial Results
04:05pm, Thursday, 27'th Feb 2025
BURLINGTON, Mass., Feb. 27, 2025 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants, and services, reported Q4 2024 results, announced an increased quarterly dividend
LeMaitre Will Announce Fourth Quarter 2024 Earnings Results February 27, 2025
03:15pm, Monday, 27'th Jan 2025
BURLINGTON, Mass., Jan. 27, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its fourth quarter 2024 financial results on Thursday, February 27, 2025
The Most Underrated Mistake Destroying Your Retirement - December Dividend Income Report
07:12am, Monday, 27'th Jan 2025
Since its inception, my portfolio has been up 177%, with a 15% annualized growth rate. At this time, I'm thinking of adding a little bit more of Telus to this portfolio. The stock has been significant
4 Healthcare Stocks Rising More Than 50% in 2024 With Room to Grow
10:11am, Tuesday, 24'th Dec 2024
Medical stocks are expected to reap the benefits of affordable health insurance plans, rising surgeries and widespread adoption of telehealth services in the days ahead. However, inflation and supply-
LeMaitre Vascular Announces Proposed Convertible Senior Notes Offering
07:57am, Monday, 16'th Dec 2024
BOSTON, Dec. 16, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (“LeMaitre”) (Nasdaq: LMAT) today announced its intention to offer, subject to market and other conditions, $150,000,000 aggregate
Final Trade: LMAT, GOOGL, IBM, GILD
06:50pm, Tuesday, 10'th Dec 2024
The final trades of the day with CNBC's Melissa Lee and the Fast Money traders.
RMD vs. LMAT: Which Stock Is the Better Value Option?
12:40pm, Tuesday, 26'th Nov 2024
Investors looking for stocks in the Medical - Products sector might want to consider either ResMed (RMD) or LeMaitre Vascular (LMAT). But which of these two companies is the best option for those look
LeMaitre to Participate at Upcoming Investor Conferences in December
05:20pm, Monday, 25'th Nov 2024
BURLINGTON, Mass., Nov. 25, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in two upcoming investor conferences in December.
LeMaitre Vascular: The Market Is Catching On To This Dividend Growth Story
04:25pm, Sunday, 03'rd Nov 2024
LeMaitre continues to expand in the peripheral vascular disease market, with recent revenue gains driven by premium pricing and international growth. Its strong dividend growth of 14.3% this year and
LeMaitre to Participate at Upcoming Investor Conferences in November
04:47pm, Friday, 01'st Nov 2024
BURLINGTON, Mass., Nov. 01, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in three upcoming investor conferences in November.
